Kindeva and Rocket Science Health Partner to Advance Novel Intranasal Delivery Platform Targeting the Olfactory Clefts

Kindeva, a global CDMO and drug delivery expert, and Rocket Science Health (RSH), a Canadian technology healthcare company, have joined forces to find pa...

June 19, 2025 | Thursday | News
Synfini and O2nix Bio Partner to Accelerate Anti-Metastatic Cancer Drug Discovery Targeting FTSJ1

Combination of World Leading Epitranscriptomics and AI-Driven Automation Aims to Accelerate Development of Cancer Therapies That Halt Metastasis  &...

June 19, 2025 | Thursday | News
Incannex and Mind Medicine Australia Launch Joint Venture to Open Psychedelic Therapies Clinic in Melbourne

Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combi...

June 18, 2025 | Wednesday | News
QIAGEN and Incyte Partner to Develop Global Companion Diagnostic Panel for CALR-Mutant Blood Cancers

QIAGEN N.V.  and Incyte  announced a new global collaboration to develop a novel diagnostic panel to support Incyte’s extensive portfolio...

June 16, 2025 | Monday | News
Chiesi Group and Key2Brain Expand Collaboration to Advance BBB-Crossing Therapies for Ultra-Rare Lysosomal Storage Disorders

Collaboration will leverage Key2Brain’s technology to develop blood-brain barrier-crossing enzyme replacement therapies for lysosomal storage disor...

June 12, 2025 | Thursday | News
XL-protein and Grifols Partner to Develop Novel Long-Acting Biopharmaceutical Using PASylation® Technology

XL-protein GmbH, a pioneer in the area of biopolymers for pharmacokinetic optimization, announced  that it has entered into a worldwide License, Dev...

June 11, 2025 | Wednesday | News
Yoneda Labs and Symeres Boost Cross-Coupling Reaction Yields from 30 to Over 90 Percent Using AI-Driven Optimization

Yoneda Labs, a leader in computational tools for reaction optimization, has successfully collaborated with Symeres, a leading transatlantic, small molecule...

June 10, 2025 | Tuesday | News
OBI Pharma and TegMine Therapeutics Enter ADC Collaboration to Target Cancer-Specific Glycans

OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies such as antibody-drug conjugate...

June 10, 2025 | Tuesday | News
SOLVE FSHD and Modalis Partner to Advance CRISPR-Based Epigenome Editing Therapy for Muscular Dystrophy

-SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), and Modalis Ther...

June 09, 2025 | Monday | News
Alvotech and Dr. Reddy’s Partner to Co-Develop Global Biosimilar for Keytruda®

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“...

June 06, 2025 | Friday | News
Agenus and Zydus Forge Strategic Partnership to Advance BOT/BAL Immunotherapy and Launch BioCDMO Operations in the U.S.

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced it has signed definitive partnership agreements with Zydus Lifescienc...

June 05, 2025 | Thursday | News
Lipella Renews Manufacturing Collaboration with Cook MyoSite to Advance Clinical Pipeline

Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on devel...

June 05, 2025 | Thursday | News
Conduit Pharmaceuticals and Manoira Partner to Advance Cross-Species Glucokinase Activator Programs in $15B Animal Health Market

Collaboration leverages cutting-edge reformulation expertise to generate cross-species insights, fast-track human clinical programs, and seeks to captu...

June 05, 2025 | Thursday | News
Recludix Pharma and Sanofi Advance Oral STAT6 Inhibitor REX-8756 Toward the Clinic for Inflammatory Diseases

Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that the company has nominated ...

June 03, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close